PROC Stock: Procaps Group S.A. Stock Price, Analysis & Insights
Get live PROC stock price $1.01, comprehensive Procaps Group S.A. stock analysis, charts, news, and expert forecast. Real-time PROC stock data and investment insights.
Loading chart data...
Procaps Group S.A. (PROC) Overview
Procaps Group S.A. (PROC) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, PROC trades at $1.01 with a market capitalization of 102.08M . Over the past 52 weeks, PROC has traded between $0.50 and $3.77 , with the current price positioned at approximately 16% of this range . The s...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 102.08M
- Current price: $1.01
- 52-week range: $0.50 - $3.77
- P/E ratio: 1.53
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Procaps Group S.A., established in Luxembourg in 1977, functions as a global pharmaceutical enterprise dedicated to the creation, production, and distribution of a broad spectrum of pharmaceutical solutions. The company manufactures and markets brand...
Company Information
- CEO
- Jose Antonio Toledo Vieira
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 5500
Contact Information
- Website
- https://www.procapsgroup.com
- Address
- 9 Rue de Bitbourg
- Country
- LU
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 1.5)
✓ Lower volatility stock (Beta: 0.17) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Procaps Group S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Procaps Group S.A.
- ⚠Investors should consider how Procaps Group S.A. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
102.08M
P/E Ratio (TTM)
1.53
Beta
0.17
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare PROC with peer companies:
- Price
- $2.35
- Market cap
- 115.91M
- Price
- $0.77
- Market cap
- 3.71M
- Price
- $5.50
- Market cap
- 120.98M
- Price
- $20.65
- Market cap
- 108.80M
- Price
- $9.60
- Market cap
- 97.22M
- Price
- $0.03
- Market cap
- 3.14M
- Price
- $1.10
- Market cap
- 116.13M
- Price
- $47.98
- Market cap
- 1.23B
- Price
- $0.87
- Market cap
- 61.25M
- Price
- $0.10
- Market cap
- 95.35M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.